About Us

Company Overview

Stepping into Taiwan Veterans Pharmaceutical is like walking through a living history of Taiwan’s pharmaceutical development.
The connection between veterans and pharmaceutical manufacturing turns the passage of time into more than distant memories—it becomes a continuing story.

榮民製藥股份有限公司

Since 1960

Taiwan Veterans Pharmaceutical is one of the production enterprises under the Veterans Affairs Council, Executive Yuan, and the only state-owned pharmaceutical manufacturer in Taiwan. In addition to producing Western medicines for hospitals affiliated with the Veterans Affairs Council, military hospitals, and major public and private medical institutions, the company also carries significant social responsibilities and multiple historical missions. These include providing employment opportunities for retired military personnel, supporting veterans and their families, contributing to national economic development, and supplying essential medicines to the armed forces during wartime.
In 2006, following the government’s privatization policy, the company entered a joint venture with Syncore Biotechnology Co., Ltd.—a reputable enterprise established in 1945. Through this partnership, the former exemplary state-owned pharmaceutical plant was reborn with a renewed identity as Taiwan Veterans Pharmaceutical Co., Ltd., carrying forward its legacy into a new era.

Company Mission

Guided by the belief that “every pill represents hope and carries a responsibility,” we have upheld our 50-year tradition of quality assurance and safety first. With the professionalism of our team and an unwavering commitment to integrity in our operations, we strive to provide the best pharmaceutical products that enhance human health.
We are dedicated to fulfilling our corporate responsibilities and contributing to a healthier, more vibrant life for the people of Taiwan. It is our mission to remain a trusted partner in safeguarding the well-being of every individual—today and always.

Company Vision

With unified dedication from all employees, we strive to drive innovation while advancing therapeutics, prevention, and healthcare development. Upholding our social mission, we aim to establish a solid foundation for sustainable growth and long-term profitability.
Guided by our management principles of Heritage & Innovation, Quality & Efficiency, and Caring Service, we are committed to enhancing corporate performance, collaborating on new drug development, cultivating exceptional talent, and fulfilling our social responsibilities.

Business Strategy

Driven by the belief in the courage to innovate, an unwavering commitment to quality, and the pursuit of healthy living, we actively advance our three strategic pillars:

  1. Diversified Marketing & Operations
  2. Technology-Driven Innovation in Production & R&D
  3. Internationalization of Brand and Distribution Channels
We are dedicated to strengthening our integration with the healthcare industry while adopting a diversified operational strategy. This includes maintaining our unique position as a public–private cooperative pharmaceutical manufacturer that bridges industry, government, academia, and research institutions. Through strategic alliances and resource integration with Syncore Biotechnology, we are building a shared strategic technology platform that supports international collaboration, technology import and export, and global market expansion—ensuring our presence on the world stage.
In addition, we continue to grow and reinforce our core business in medical products, while also exploring opportunities in biotechnology, health and wellness, geriatric medicine, medical aesthetics, and cultural tourism. By collaborating with outstanding partners and expanding cross-industry alliances, we aim to drive profitability, achieve sustainable growth, and position ourselves as a model enterprise within the pharmaceutical industry.
Scroll to Top